Navigating the 2021 update to the IDSA/SHEA Clostridioides difficile guidelines: An ethical approach to equitable patient care.

Journal Article (Editorial)

The 2021 focused update to the Infections Diseases Society of America/Society for Healthcare Epidemiology of America (IDSA/SHEA) guidelines for management of Clostridioides difficile infection (CDI) prioritizes the use of fidaxomicin over vancomycin for the treatment of initial and recurrent CDI. These recommendations have significant clinical and financial ramifications for hospitals and patients with CDI. Antimicrobial stewardship programs must balance the needs, goals, and barriers faced by patients and health systems when determining the best treatment strategy for CDI. In this commentary, we provide antimicrobial stewardship programs with a decision-making framework that acknowledges the fundamental principles of ethics to provide equitable patient care.

Full Text

Duke Authors

Cited Authors

  • Shoff, CJ; Spires, SS; Yen, C; Advani, SD

Published Date

  • 2022

Published In

Volume / Issue

  • 2 / 1

Start / End Page

  • e70 -

PubMed ID

  • 36483335

Pubmed Central ID

  • PMC9726573

Electronic International Standard Serial Number (EISSN)

  • 2732-494X

Digital Object Identifier (DOI)

  • 10.1017/ash.2022.49


  • eng

Conference Location

  • England